← FDA Drug Approvals (Drugs@FDA)

CLORAZEPATE DIPOTASSIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2022-06-16

Drug application

FDA Application #

ANDA213730

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLORAZEPATE DIPOTASSIUM

Generic name

CLORAZEPATE DIPOTASSIUM

Active ingredients

CLORAZEPATE DIPOTASSIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NOVITIUM PHARMA

Manufacturer

ANI Pharmaceuticals, Inc.

First approval

2022-06-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown